Expert Roundtable: Navigating the Next Phase of Low Carbon pMDI Development
In May 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the world's first low carbon pressurised Metered Dose Inhaler (pMDI). For an...















